Anzeige
Mehr »
Dienstag, 21.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

BEL-20 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im BEL-20

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
MoGBL: GBL - Transactions on GBL shares 20-04-20261
MoInterview with Laurein Cornelissen, Team Lead Expertise Power Transformers at Elia3
MoBERNSTEIN RESEARCH stuft AB Inbev auf 'Outperform'500NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für AB Inbev von 83 auf 87 Euro angehoben und die Einstufung auf "Outperform" belassen. Trevor Stirling zog in einer...
► Artikel lesen
MoUCB Proposes $650M Acquisition of Neurona Therapeutics5
MoUCB to purchase Neurona and NRTX-1001 for $1.15bn1
MoUCB cuts $1.15bn deal to buy epilepsy biotech Neurona4
MoARGENX SE - 6-K, Report of foreign issuer1
MoItaly's private equity weekly roundup. News from BeBeez, Di Luccia & Partners, Banca Investis, Duke&Kay, Recordati, CVC, Groupe Bruxelles Lambert, Adia, Gic, Caisse de Depot et Placement du Quebec, and more5
MoKBC Groep: Notification for bondholders of KBC IFIMA234Following document is available on www.kbc.com: - 2025 financial report of KBC IFIMA
► Artikel lesen
MoANHEUSER-BUSCH INBEV SA/NV - Disclosure Made According to the Requirements of the Law of 2 May 20074
SaShould Altria sell off its Anheuser-Bush InBev stake? It's complicated39
Saargenx SE: argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP4
FrUCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B2
FrBelgian pharma UCB to buy U.S.-based Neurona for up to $1.15B4
FrUCB übernimmt Neurona Therapeutics für bis zu 1,15 Milliarden US-Dollar2
FrUCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine3
FrUCB to acquire Neurona Therapeutics for up to $1.15 billion2
FrUCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science961Acquisition builds on UCB's 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generation disease-modifying therapies. ...
► Artikel lesen
FrUmicore - Transparency notification by Amundi SA4
FrAgeas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV281 Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV As the quorum required for the Extraordinary General Meeting of Shareholders of Wednesday 22 April...
► Artikel lesen
Weiter >>